| 
           Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
            The web pages are not kept up to date and are for demonstration purposes only. 
            For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. 
         | 
        BACK TO LIST | 
                     
  | 
                  
                     
 
  | 
                  
                     
 
  | 
               |||||||||||||||||||||||||
| Test | 19-JUL-2019 | Reference Range | Unit | 
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 7.0 H | 4 - 6 | % | 
| Glucose [Mass/volume] in Blood | 111.9 | 70 - 140 | mg/dL | 
| Urea nitrogen [Mass/volume] in Blood | 15.7 | 7 - 25 | mg/dL | 
| Creatinine [Mass/volume] in Blood | 0.7 | 0.6 - 1.1 | mg/dL | 
| Calcium [Mass/volume] in Blood | 9.9 | 8.5 - 10.4 | mg/dL | 
| Sodium [Moles/volume] in Blood | 140.9 | 135 - 145 | mmol/L | 
| Potassium [Moles/volume] in Blood | 4.8 | 3.5 - 5.1 | mmol/L | 
| Chloride [Moles/volume] in Blood | 101.2 | 98 - 107 | mmol/L | 
| Carbon dioxide, total [Moles/volume] in Blood | 20.4 L | 22 - 29 | mmol/L | 
| Cholesterol [Mass/volume] in Serum or Plasma | 206.2 H | 125 - 200 | mg/dL | 
| Triglyceride [Mass/volume] in Serum or Plasma | 168.1 H | 35 - 150 | mg/dL | 
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 132.4 H | 0 - 130 | mg/dL | 
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 40.1 | 40 - 100 | mg/dL | 
| Microalbumin/Creatinine [Mass Ratio] in Urine | 9.4 | 0 - 30 | mg/g | 
| Conclusion and Recommendations based on this report and previous findings known to us | 
|---|
| The patient shows poor glycemic control (elevated HbA1c), mild dyslipidemia (high total cholesterol, LDL, and triglycerides), and low total CO₂, which may suggest mild metabolic acidosis. Renal function and electrolytes are within normal limits, and there is no evidence of microalbuminuria. Recommend optimization of diabetes and lipid management and further evaluation of acid-base status if clinically indicated. |